GSDMD and metabolic dysfunction-associated steatotic liver disease: Compared to controls, patients with NAFLD/NASH exhibit elevated levels of hepatic GSDMD and GSDMD-NT proteins, with particularly heightened expression of GSDMD-NT observed in those with NASH.